Shifting Strategies in the Treatment of Pediatric Craniopharyngioma

Curr Oncol Rep. 2023 Dec;25(12):1497-1513. doi: 10.1007/s11912-023-01471-9. Epub 2023 Nov 28.

Abstract

Purpose of review: Craniopharyngiomas represent one of the most challenging diseases to treat. Despite their benign histology, and after many decades of surgical experience and technological advancements, there is still no clear consensus regarding the most effective management for this tumor. Due to their location and aggressive local characteristics, purely surgical approaches all too often result in unacceptable morbidity.

Recent findings: Partial resection combined with radiation therapy results in similar control rates when compared to aggressive surgery, while also minimalizing the neuro-endocrinological morbidity. In this manuscript, we describe the historical progression of the shifting strategies in the management of pediatric craniopharyngioma. Time has also altered our expectations for outcomes, evolving from purely morbidity and mortality to simple Glasgow Outcomes Scales, now to formal neuro-psychometric and quality of life data.

Keywords: Blindness; Brain tumor; Craniopharyngioma; Endoscopy; Hydrocephalus; Minimally invasive treatment; Morbidity; Pediatric; Protons; Radiotherapy.

Publication types

  • Review

MeSH terms

  • Child
  • Combined Modality Therapy
  • Craniopharyngioma* / pathology
  • Craniopharyngioma* / surgery
  • Humans
  • Pituitary Neoplasms* / surgery
  • Quality of Life
  • Retrospective Studies
  • Treatment Outcome